Active, not recruitingNot applicableNCT04058990

Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Boston Scientific Corporation
Principal Investigator: Masato Nakamura, MD
Toho University Ohashi Medical Center
Intervention: Device: Paclitaxel-Coated PTCA Balloon Catheter(device)
Enrollment: 180 target
Eligibility: 20 years · All sexes
Timeline: 2019 – 2026

Study locations (14)

Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan
Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan
Japan Labour Health and Welfare Organization Kanto Rosai Hospital, Kawasaki, Kanagawa, Japan
Shonan Kamakura General Hospital, Ōfuna, Kanagawa, Japan
Saiseikai Yokohama-City Eastern Hospital, Yokohama, Kanagawa, Japan
Kyoto-Katsura Hospital, Kyoto, Kyoto, Japan
Sendai Kousei Hospital, Sendai, Miyagi, Japan
Miyazaki Medical Association Hospital, Miyazaki, Miyazaki, Japan
Osaka Saiseikai Nakatsu Hospital, Kita, Osaka, Japan
Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka, Osaka, Japan
Toho University Ohashi Medical Center, Meguro City, Tokyo, Japan
Showa Medical University Hospital, Shinagawa-Ku, Tokyo, Japan
Tokyo Women's Medical University Hospital, Shinjuku-Ku, Tokyo, Japan
Teikyo University Hospital, tabashi City, Tokyo, Japan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04058990 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials